News

Policy and perspectives

Exploring the implications of policy change, evolving evidence requirements and healthcare market developments.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Events

MedTech

The Value of Technology to Reduce Barriers to Clinical Trial Diversity and Facilitate the Development of Patient-Centric Medicines

Maddy Dawson and Nancy Cross present research at ISPOR Europe 2022

08 Nov 2022

JCA

Events

The Impact of the EU-JCA throughout European Healthcare Systems

Jake James presents research at ISPOR Europe 2022 exploring the impact the EU-JCA will have throughout European healthcare systems (HTA93)

07 Nov 2022

VALUE & ACCESS

PRICING

Germany: Approval of the cost-containment bill

Doris De Causmaecker reports on this significant news

21 Oct 2022

VALUE & ACCESS

PRICING

France: Draft PLFSS 2023

Yasmina Zegaoui writes about the affect, if implemented, the PLFSS will have on the price of medicines and the impact on manufacturers

07 Oct 2022

VALUE & ACCESS

Is REvalMed facilitating or hindering orphan drug access in Spain? A report by the AELMHU

Jake James, Analyst, investigates this further

06 Jul 2022

VALUE & ACCESS

Australia: Government plans to reshape the healthcare landscape

Jake James looks at the government’s plans to shape the healthcare landscape in the coming years

09 Jun 2022

VALUE & ACCESS

An overview of psychedelic drugs in clinical development

Nancy Cross reviews the current R&D pipeline for psychedelic drugs

24 May 2022

VALUE & ACCESS

The growing field of psychedelic research in psychiatric diseases and mental health

Nancy Cross provides a brief background on psychedelics and their use in medicine and clinical research

18 May 2022

VALUE & ACCESS

China: Draft policy that could impact the EDL, paediatrics and rare diseases

Xin Zhao maps out the impact these potential new regulations could have

17 May 2022

VALUE & ACCESS

Germany: Planned reform to hospitals

Maddy Dawson shares an overview of the planned reform

16 May 2022

VALUE & ACCESS

PRICING

TLV presents proposal to the Swedish government to facilitate pricing negotiations for new gene therapies

Jake James takes a look at the recent proposal by the TLV

12 May 2022

VALUE & ACCESS

Poland: Withdraws from contractual purchasing commitments for the Covid-19 vaccine

Eleanor Butler takes a closer look at this recent development

11 May 2022